ongitudinal analysis of actual treatment strategies in hematologic / cancer patients in relation to age (<70 y./=70 y.)
Recruiting
- Conditions
- All hematologic / cancer diseases. 1st. analysis: colorectal cancer, breast cancer, lung cancer, lymphoma
- Registration Number
- DRKS00013113
- Lead Sponsor
- Onkotrakt AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100000
Inclusion Criteria
hematologic / cancer patients with medical therapy > 18 years with informed consent
Exclusion Criteria
age < 18 years, no written informed consent, or patients which are not able to give consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Examination of the effectiveness and representativity of the newly developed registry<br><br>2. patient`s age < 70 vs. =70 years: influence of age on therapy choice or -intensity (percentage of multidrug therapies, duration of therapies, administered courses of therapy per line, mean intervals of cycles, dose modifications)
- Secondary Outcome Measures
Name Time Method 3) tumour entity: differences in total duration of therapy, lines, modifications of drug dose depending on disease<br>4) therapy protocol: is there any correlation between therapy duration, therapy protocol and patients age? <br>5) Intensity and line: in which therapy line do the most dose modifications occur ?